This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Institut De Recherche Pour Le Developpement (Ird), Universitè De Montpellier. Active years: 2018.
Company Filing History:



Years Active: 2018
Title: The Innovative Contributions of Stephane Delbecq
Introduction
Stephane Delbecq is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating parasitic diseases. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Delbecq holds a patent for "N-hydroxybenzamides as HDAC inhibitors for the treatment of parasitic diseases." This patent describes compounds of a specific formula, wherein n is 0, 1, or 2; X is a defined group, and Ar is a benzyl substituted at the meta position by a Cto Calkoxy group. These compounds are designed for treating, preventing, or inhibiting parasitic diseases, such as toxoplasmosis, in subjects. The patent also presents methods for preparing these compounds, showcasing Delbecq's innovative approach to addressing health issues.
Career Highlights
Throughout his career, Delbecq has been associated with prestigious institutions such as Université de Montpellier and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to contribute to significant advancements in research and development in the field of parasitology.
Collaborations
Delbecq has collaborated with esteemed colleagues, including Corinne Loeuillet and Jean-Francois Alexandre Guichou. These partnerships have further enriched his research and have led to impactful findings in the realm of medicinal chemistry.
Conclusion
Stephane Delbecq's innovative work in developing HDAC inhibitors represents a significant advancement in the treatment of parasitic diseases. His contributions to science and medicine continue to inspire future research and innovation in the field.